Skip to main content
Erschienen in: Urolithiasis 5/2022

25.07.2022 | Original Article

Observation and identification of autofluorescent urine crystals may be linked to a sign of urolithiasis

verfasst von: Syue-Liang Lin, Chen-Yuan Chung, Zih-Ting Chen, Chih-Chia Huang, Yun-Zhen Li, Eric Yi-Hsiu Huang, Huihua Kenny Chiang

Erschienen in: Urolithiasis | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Urolithiasis is a common disease of the urinary system. Its recurrence rate is high and may increase medical expenses. Urine stones are composed of urine crystals and other impurities. We discovered the existence of autofluorescence in some of the urine crystals, especially in urolithiasis patients. The fluorescent molecule existed in urine crystals was verified and identified. We have applied micro-Raman and fluorescence microscopy to classify the urine crystals, used confocal laser scanning microscopy (CLSM) to examine the 3D images and spectra of autofluorescence in crystals, used Fourier-transform infrared spectroscopy (FTIR) and mass spectrometry (MS) to identify the type of fluorophore in the autofluorescent urine crystals in urine. Riboflavin was identified as one of the major fluorophores in these autofluorescent urine crystals. The prevalence rates of the autofluorescent crystals in urolithiasis patients and subjects without the history of urolithiasis were to gather statistics. We observed that 80% of urolithiasis patients had autofluorescent crystals. Contrastingly, such crystals existed in only 7% of subjects without the history of urolithiasis. The presence of autofluorescent urine crystals may be linked to a sign of urolithiasis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bihl G, Meyers A (2001) Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet 358(9282):651–656CrossRef Bihl G, Meyers A (2001) Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet 358(9282):651–656CrossRef
2.
Zurück zum Zitat Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327(16):1141–1152CrossRef Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327(16):1141–1152CrossRef
3.
Zurück zum Zitat Worcester EM, Coe FL (2010) Calcium kidney stones. N Engl J Med 363(10):954–963CrossRef Worcester EM, Coe FL (2010) Calcium kidney stones. N Engl J Med 363(10):954–963CrossRef
4.
Zurück zum Zitat Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ (2007) The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series 5(3):126–136CrossRef Basavaraj DR, Biyani CS, Browning AJ, Cartledge JJ (2007) The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU Update Series 5(3):126–136CrossRef
5.
Zurück zum Zitat Han H, Segal AM, Seifter JL, Dwyer JT (2015) Nutritional management of kidney stones (nephrolithiasis). Clin Nutr Res 4(3):137–152CrossRef Han H, Segal AM, Seifter JL, Dwyer JT (2015) Nutritional management of kidney stones (nephrolithiasis). Clin Nutr Res 4(3):137–152CrossRef
6.
Zurück zum Zitat Robertson WG, Peacock M, Nordin BEC (1971) Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci 40(5):365–374CrossRef Robertson WG, Peacock M, Nordin BEC (1971) Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. Clin Sci 40(5):365–374CrossRef
7.
Zurück zum Zitat Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53(1):166–181CrossRef Werness PG, Bergert JH, Smith LH (1981) Crystalluria. J Cryst Growth 53(1):166–181CrossRef
9.
Zurück zum Zitat Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P (2005) Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 67(5):1934–1943CrossRef Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P (2005) Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 67(5):1934–1943CrossRef
10.
Zurück zum Zitat Lu HS-H, Chen K-K, Lin AT, Chang Y-H, Wu HH, Hsu TH, Chang LS (1994) Urinary crystals in patients with and without urolithiasis. J Urol Assoc ROC 5(3):163–168 Lu HS-H, Chen K-K, Lin AT, Chang Y-H, Wu HH, Hsu TH, Chang LS (1994) Urinary crystals in patients with and without urolithiasis. J Urol Assoc ROC 5(3):163–168
11.
Zurück zum Zitat Lo P-A, Huang Y-H, Chiu Y-C, Huang L-C, Bai J-L, Wu S-H, Huang C-C, Chiang HK (2019) Automatic Raman spectroscopic urine crystal identification system using fluorescent image-guided 2D scanning platform with Fe3O4 crystal violet nanoclusters. J Raman Spectrosc 50(1):34–40CrossRef Lo P-A, Huang Y-H, Chiu Y-C, Huang L-C, Bai J-L, Wu S-H, Huang C-C, Chiang HK (2019) Automatic Raman spectroscopic urine crystal identification system using fluorescent image-guided 2D scanning platform with Fe3O4 crystal violet nanoclusters. J Raman Spectrosc 50(1):34–40CrossRef
12.
Zurück zum Zitat Kesson A, Talbott J, Gyory A (1978) Microscopic examination of urine. Lancet 312(8094):809–812CrossRef Kesson A, Talbott J, Gyory A (1978) Microscopic examination of urine. Lancet 312(8094):809–812CrossRef
13.
Zurück zum Zitat Fontanella CG, Carniel EL (2021) Computational tools for the investigation of the male lower urinary tract functionality in health and disease. J Med Biol Eng 41(2):203–215CrossRef Fontanella CG, Carniel EL (2021) Computational tools for the investigation of the male lower urinary tract functionality in health and disease. J Med Biol Eng 41(2):203–215CrossRef
14.
Zurück zum Zitat Chien T-I, Kao J-T, Liu H-L, Lin P-C, Hong J-S, Hsieh H-P, Chien M-J (2007) Urine sediment examination: a comparison of automated urinalysis systems and manual microscopy. Clin Chim Acta 384(1):28–34CrossRef Chien T-I, Kao J-T, Liu H-L, Lin P-C, Hong J-S, Hsieh H-P, Chien M-J (2007) Urine sediment examination: a comparison of automated urinalysis systems and manual microscopy. Clin Chim Acta 384(1):28–34CrossRef
15.
Zurück zum Zitat Krafft C, Steiner G, Beleites C, Salzer R (2009) Disease recognition by infrared and Raman spectroscopy. J biophotonics 2(1–2):13–28CrossRef Krafft C, Steiner G, Beleites C, Salzer R (2009) Disease recognition by infrared and Raman spectroscopy. J biophotonics 2(1–2):13–28CrossRef
16.
Zurück zum Zitat Butler HJ, Ashton L, Bird B, Cinque G, Curtis K, Dorney J, Esmonde-White K, Fullwood NJ, Gardner B, Martin-Hirsch PL (2016) Using Raman spectroscopy to characterize biological materials. Nat Protoc 11(4):664–687CrossRef Butler HJ, Ashton L, Bird B, Cinque G, Curtis K, Dorney J, Esmonde-White K, Fullwood NJ, Gardner B, Martin-Hirsch PL (2016) Using Raman spectroscopy to characterize biological materials. Nat Protoc 11(4):664–687CrossRef
17.
Zurück zum Zitat Chiu YC, Yang HY, Lu SH, Chiang HK (2010) Micro-Raman spectroscopy identification of urinary stone composition from ureteroscopic lithotripsy urine powder. J Raman Spectrosc 41(2):136–141 Chiu YC, Yang HY, Lu SH, Chiang HK (2010) Micro-Raman spectroscopy identification of urinary stone composition from ureteroscopic lithotripsy urine powder. J Raman Spectrosc 41(2):136–141
18.
Zurück zum Zitat Chiu Y-C, Chen P-A, Chang P-Y, Hsu C-Y, Tao C-W, Huang C-C, Chiang HK (2015) Enhanced Raman sensitivity and magnetic separation for urolithiasis detection using phosphonic acid-terminated Fe3O4 nanoclusters. J Mater Chem B 3(20):4282–4290CrossRef Chiu Y-C, Chen P-A, Chang P-Y, Hsu C-Y, Tao C-W, Huang C-C, Chiang HK (2015) Enhanced Raman sensitivity and magnetic separation for urolithiasis detection using phosphonic acid-terminated Fe3O4 nanoclusters. J Mater Chem B 3(20):4282–4290CrossRef
19.
Zurück zum Zitat Chen Z-T, Wang C-H, Chiang HK (2020) Characterization of auto-fluorescence urine crystals from gout patients using confocal microscopy and micro-Raman system for urolithiasis prediction. Proc of SPIE 11359:113591P Chen Z-T, Wang C-H, Chiang HK (2020) Characterization of auto-fluorescence urine crystals from gout patients using confocal microscopy and micro-Raman system for urolithiasis prediction. Proc of SPIE 11359:113591P
20.
Zurück zum Zitat Sours RE, Fink DA, Cox KA, Swift JA (2005) Uric acid dye inclusion crystals. Mol Cryst Liq Cryst 440(1):187–193CrossRef Sours RE, Fink DA, Cox KA, Swift JA (2005) Uric acid dye inclusion crystals. Mol Cryst Liq Cryst 440(1):187–193CrossRef
21.
Zurück zum Zitat Elmer P (2005) Spectroscopy attenuated total reflectance (ATR). Technical Note 27(11):1 Elmer P (2005) Spectroscopy attenuated total reflectance (ATR). Technical Note 27(11):1
22.
Zurück zum Zitat Ho CS, Lam C, Chan M, Cheung R, Law L, Lit L, Ng K, Suen M, Tai H (2003) Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 24(1):3PubMedPubMedCentral Ho CS, Lam C, Chan M, Cheung R, Law L, Lit L, Ng K, Suen M, Tai H (2003) Electrospray ionisation mass spectrometry: principles and clinical applications. Clin Biochem Rev 24(1):3PubMedPubMedCentral
23.
Zurück zum Zitat Sekkoum K, Cheriti A, Taleb S, Belboukhari N (2016) FTIR spectroscopic study of human urinary stones from El Bayadh district (Algeria). Arab J Chem 9(3):330–334CrossRef Sekkoum K, Cheriti A, Taleb S, Belboukhari N (2016) FTIR spectroscopic study of human urinary stones from El Bayadh district (Algeria). Arab J Chem 9(3):330–334CrossRef
24.
Zurück zum Zitat He JY, Deng SP, Ouyang JM (2010) Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients. IEEE Trans NanoBioscience 9(2):156–163CrossRef He JY, Deng SP, Ouyang JM (2010) Morphology, particle size distribution, aggregation, and crystal phase of nanocrystallites in the urine of healthy persons and lithogenic patients. IEEE Trans NanoBioscience 9(2):156–163CrossRef
25.
Zurück zum Zitat Zhang Y, Wang Y, Cao W-W, Ma K-T, Ji W, Han Z-W, Si J-Q, Li L (2018) Spectral characteristics of autofluorescence in renal tissue and methods for reducing fluorescence background in confocal laser scanning microscopy. J Fluoresc 28(2):561–572CrossRef Zhang Y, Wang Y, Cao W-W, Ma K-T, Ji W, Han Z-W, Si J-Q, Li L (2018) Spectral characteristics of autofluorescence in renal tissue and methods for reducing fluorescence background in confocal laser scanning microscopy. J Fluoresc 28(2):561–572CrossRef
26.
Zurück zum Zitat Trinchieri A, Lizzano R, Marchesotti F, Zanetti G (2006) Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers. Urol Res 34(1):1–7CrossRef Trinchieri A, Lizzano R, Marchesotti F, Zanetti G (2006) Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers. Urol Res 34(1):1–7CrossRef
27.
Zurück zum Zitat Zheng Y, Dong J, Palfey BA, Carey PR (1999) Using Raman spectroscopy to monitor the solvent-exposed and “buried” forms of flavin in p-hydroxybenzoate hydroxylase. Biochemistry 38(51):16727–16732CrossRef Zheng Y, Dong J, Palfey BA, Carey PR (1999) Using Raman spectroscopy to monitor the solvent-exposed and “buried” forms of flavin in p-hydroxybenzoate hydroxylase. Biochemistry 38(51):16727–16732CrossRef
28.
Zurück zum Zitat Unno M, Sano R, Masuda S, Ono T-a, Yamauchi S (2005) Light-induced structural changes in the active site of the BLUF domain in AppA by Raman spectroscopy. J Phys Chem B 109(25):12620–12626CrossRef Unno M, Sano R, Masuda S, Ono T-a, Yamauchi S (2005) Light-induced structural changes in the active site of the BLUF domain in AppA by Raman spectroscopy. J Phys Chem B 109(25):12620–12626CrossRef
29.
Zurück zum Zitat Pearle MS, Nakada SY (2014) Practical Controversies in medical management of stone disease, vol 20. Springer, New YorkCrossRef Pearle MS, Nakada SY (2014) Practical Controversies in medical management of stone disease, vol 20. Springer, New YorkCrossRef
30.
Zurück zum Zitat Stapleton A, Simpson R, Ryall RL (1993) Crystal matrix protein is related to human prothrombin. Biochem Biophys Res Commun 195(3):1199–1203CrossRef Stapleton A, Simpson R, Ryall RL (1993) Crystal matrix protein is related to human prothrombin. Biochem Biophys Res Commun 195(3):1199–1203CrossRef
31.
Zurück zum Zitat Stapleton A, Ryall RL (1995) Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the Fl activation peptide of human prothrombin. Br J Urol 75(6):712–719CrossRef Stapleton A, Ryall RL (1995) Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the Fl activation peptide of human prothrombin. Br J Urol 75(6):712–719CrossRef
32.
Zurück zum Zitat Cook AF, Grover PK, Ryall RL (2009) Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int 103(6):826–835CrossRef Cook AF, Grover PK, Ryall RL (2009) Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int 103(6):826–835CrossRef
Metadaten
Titel
Observation and identification of autofluorescent urine crystals may be linked to a sign of urolithiasis
verfasst von
Syue-Liang Lin
Chen-Yuan Chung
Zih-Ting Chen
Chih-Chia Huang
Yun-Zhen Li
Eric Yi-Hsiu Huang
Huihua Kenny Chiang
Publikationsdatum
25.07.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 5/2022
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-022-01343-0

Weitere Artikel der Ausgabe 5/2022

Urolithiasis 5/2022 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.